PL1....PPHM---That mAB has as good or better chance of eradicating and leaving the virus as non mutatable as any Protease inhibitor or even IDIX's drug in trial now.
Well, Bavi is still early in human clinical studies. PPHM will have to present strong human efficacy and safety data to BP proving such....and convince patients that Bavi IV treatment is superior or equal to the investigational nukes that are being partnered this early.
Market Data 
Markets 
AI
